On June 9, 2022 EXACT Therapeutics AS ("EXACT-Tx", "the Company" Euronext Growth: EXTX) reported a share capital increase in connection with the Company’s restricted stock unit (RSU) programme (Press release, Exact Therapeutics, JUN 9, 2022, View Source [SID1234616526]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Anders Wold, Chair of EXACT-Tx, has subscribed for 2,414 shares at NOK 19.00 per share. Following this transaction, Anders Wold will hold 2,414 shares in EXACT-Tx.